Back to Results
First PageMeta Content
Vemurafenib / BRAF / Daiichi Sankyo / Ipilimumab / Immunotherapy / Bolt / Chemotherapy / Medicine / Cancer treatments / Melanoma


Expert Oncology Panel Discusses the Melanoma Development Pipeline in New BOLT / MedPredict Report In February 2013 BOLT International / MedPredict’s Melanoma Advisory Board discussed how new data and clinical findings
Add to Reading List

Document Date: 2013-04-02 11:26:29

Open Document

File Size: 138,99 KB

Share Result on Facebook

City

Scottsdale / /

Company

Sankyo / Pfizer / GlaxoSmithKline / MedPredict Market Research / Aventis / Exelixis / Novartis / Merck / Eisai / Sanofi / PRWEB / Amgen / Celgene / Genentech / Bristol-Myers Squibb / /

Event

M&A / /

Facility

Melanoma Development Pipeline / /

IndustryTerm

trial protocols / Online Web / online version / online visibility tool / pharmaceutical competitive intelligence / /

MedicalCondition

tumor / disease / brain metastases / melanoma / /

MedicalTreatment

immunotherapies / chemotherapy / immunotherapy / adjuvant therapy / /

Organization

MedPredict’s Melanoma Advisory Board / /

Person

Jeff Berk / /

/

Position

lead author / Melanoma Thought Leader / global physician / /

Product

Abraxane / /

Technology

chemotherapy / trial protocols / /

URL

http /

SocialTag